Compare Ginkgo Bioworks Holdings Inc (DNA) vs General Motors Company (GM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs General Motors Company — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while General Motors Company trades at $89 (market cap $78.40B). The key difference: General Motors Company is far larger — about 155× Ginkgo Bioworks Holdings Inc's market cap, and General Motors Company pays a 0.81% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | GM | |
|---|---|---|
Market Cap | $505.73M | $78.40B |
Sector | Health | Consumer Cyclical |
52-Week High | $16.14 | $90.30 |
52-Week Low | $5.48 | $54.16 |
Enterprise Value | $607.68M | $181.38B |
Dividend Yield | — | 0.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About General Motors Company
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company lost its U.S. market share leader crown in 2021 with share down 280 basis points to 14.6%, but we expect GM to reclaim the top spot in 2022 as 2021 suffered from the chip shortage. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.
Read more on GM →
